About the Authors
- Giovanni Corona
-
Contributed equally to this work with: Giovanni Corona, Corinna Giuliani, Gabriele Parenti
Affiliation Endocrinology Unit, Maggiore-Bellaria Hospital, Bologna, Italy
- Corinna Giuliani
-
Contributed equally to this work with: Giovanni Corona, Corinna Giuliani, Gabriele Parenti
Affiliation Endocrine Unit, “Center for Research, Transfer and High Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders for the Development of Novel Therapies” (DENOThe), Dept. of Experimental and Clinical Biomedical Sciences, University of Florence, Careggi Hospital, Florence, Italy
- Gabriele Parenti
-
Contributed equally to this work with: Giovanni Corona, Corinna Giuliani, Gabriele Parenti
Affiliation Endocrine Unit, “Center for Research, Transfer and High Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders for the Development of Novel Therapies” (DENOThe), Dept. of Experimental and Clinical Biomedical Sciences, University of Florence, Careggi Hospital, Florence, Italy
- Dario Norello
-
Affiliation Endocrine Unit, “Center for Research, Transfer and High Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders for the Development of Novel Therapies” (DENOThe), Dept. of Experimental and Clinical Biomedical Sciences, University of Florence, Careggi Hospital, Florence, Italy
- Joseph G. Verbalis
-
Affiliation Division of Endocrinology and Metabolism, Georgetown University, Washington, DC, United States of America
- Gianni Forti
-
Affiliation Endocrine Unit, “Center for Research, Transfer and High Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders for the Development of Novel Therapies” (DENOThe), Dept. of Experimental and Clinical Biomedical Sciences, University of Florence, Careggi Hospital, Florence, Italy
- Mario Maggi
-
Affiliation Andrology Unit, “Center for Research, Transfer and High Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders for the Development of Novel Therapies” (DENOThe), Dept. of Experimental and Clinical Biomedical Sciences, University of Florence, Careggi Hospital, Florence, Italy
- Alessandro Peri
-
* E-mail: alessandro.peri@unifi.it
Affiliation Endocrine Unit, “Center for Research, Transfer and High Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders for the Development of Novel Therapies” (DENOThe), Dept. of Experimental and Clinical Biomedical Sciences, University of Florence, Careggi Hospital, Florence, Italy
Competing Interests
Joseph G. Verbalis has served as a consultant and member of advisory boards and Speakers' Bureau for Astellas Pharma US, Inc., as a consultant and member of advisory boards for Sanofi-Aventis, and as a consultant for Otsuka; Alessandro Peri has served as a consultant and member of advisory boards for Otsuka. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Giovanni Corona, Corinna Giuliani, Gabriele Parenti, Dario Norello, Gianni Forti and Mario Maggi have nothing to disclose.
Author Contributions
Conceived and designed the experiments: GC CG GP DN JGV GF MM AP. Performed the experiments: GC CG GP DN. Analyzed the data: GC JGV GF MM AP. Contributed reagents/materials/analysis tools: AP GC MM GF. Wrote the paper: GC CG AP JGV.